Cargando…
COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267419/ https://www.ncbi.nlm.nih.gov/pubmed/32384171 http://dx.doi.org/10.1111/bcp.14358 |
| _version_ | 1783541443381428224 |
|---|---|
| author | Back, David Marzolini, Catia Hodge, Catherine Marra, Fiona Boyle, Alison Gibbons, Sara Burger, David Khoo, Saye |
| author_facet | Back, David Marzolini, Catia Hodge, Catherine Marra, Fiona Boyle, Alison Gibbons, Sara Burger, David Khoo, Saye |
| author_sort | Back, David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7267419 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72674192020-06-03 COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions Back, David Marzolini, Catia Hodge, Catherine Marra, Fiona Boyle, Alison Gibbons, Sara Burger, David Khoo, Saye Br J Clin Pharmacol Letters to the Editor John Wiley and Sons Inc. 2020-05-13 2021-01 /pmc/articles/PMC7267419/ /pubmed/32384171 http://dx.doi.org/10.1111/bcp.14358 Text en © 2020 The Authors. British Journal of Clinical Pharmacology published by John Wiley & Sons Ltd on behalf of British Pharmacological Society https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters to the Editor Back, David Marzolini, Catia Hodge, Catherine Marra, Fiona Boyle, Alison Gibbons, Sara Burger, David Khoo, Saye COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions |
| title | COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions |
| title_full | COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions |
| title_fullStr | COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions |
| title_full_unstemmed | COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions |
| title_short | COVID‐19 treatment in patients with comorbidities: Awareness of drug‐drug interactions |
| title_sort | covid‐19 treatment in patients with comorbidities: awareness of drug‐drug interactions |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7267419/ https://www.ncbi.nlm.nih.gov/pubmed/32384171 http://dx.doi.org/10.1111/bcp.14358 |
| work_keys_str_mv | AT backdavid covid19treatmentinpatientswithcomorbiditiesawarenessofdrugdruginteractions AT marzolinicatia covid19treatmentinpatientswithcomorbiditiesawarenessofdrugdruginteractions AT hodgecatherine covid19treatmentinpatientswithcomorbiditiesawarenessofdrugdruginteractions AT marrafiona covid19treatmentinpatientswithcomorbiditiesawarenessofdrugdruginteractions AT boylealison covid19treatmentinpatientswithcomorbiditiesawarenessofdrugdruginteractions AT gibbonssara covid19treatmentinpatientswithcomorbiditiesawarenessofdrugdruginteractions AT burgerdavid covid19treatmentinpatientswithcomorbiditiesawarenessofdrugdruginteractions AT khoosaye covid19treatmentinpatientswithcomorbiditiesawarenessofdrugdruginteractions |